Although preliminary regulatory-led analyses of post-marketing data have not found conclusive evidence of a causal link [14], and in the absence of evidence from large, randomised clinical trials, observational studies adequately designed to assess the comparative safety of treatments, employing an active comparator, new user design, are warranted to evaluate the risk of SIS in individuals treated with GLP-1RA
Meet with Our Doctor Meet with our doctor to discuss your medical history, how peptide therapy works, potential side effects, and what to expect during treatment
Ever wonder if you could naturally trigger the same appetite-curbing effects that make popular weight-loss medications so effective
Comprehensive Evaluation Highly cost-effective, making it suitable for students or as a basic whitening maintenance supplement
Seek help with your mental health ASAP